205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.77%
Revenue growth of 0.77% while QCOM is flat. Bruce Berkowitz would check if a small edge can widen further.
3.40%
Gross profit growth of 3.40% while QCOM is zero. Bruce Berkowitz would see if minimal improvements could expand further.
45.05%
EBIT growth of 45.05% while QCOM is zero. Bruce Berkowitz would see if small gains can be scaled further.
45.05%
Operating income growth of 45.05% while QCOM is zero. Bruce Berkowitz would see if this modest edge can become significant.
28.03%
Net income growth of 28.03% while QCOM is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
23.08%
EPS growth of 23.08% while QCOM is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
23.08%
Diluted EPS growth of 23.08% while QCOM is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
-5.09%
Share reduction while QCOM is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-5.09%
Reduced diluted shares while QCOM is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-29.19%
Dividend reduction while QCOM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-105.00%
Negative OCF growth while QCOM is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
1.87%
FCF growth of 1.87% while QCOM is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
44.13%
10Y revenue/share CAGR under 50% of QCOM's 94.83%. Michael Burry would suspect a lasting competitive disadvantage.
38.38%
5Y revenue/share CAGR under 50% of QCOM's 94.83%. Michael Burry would suspect a significant competitive gap or product weakness.
15.51%
3Y revenue/share CAGR under 50% of QCOM's 94.83%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-37.91%
Negative 10Y net income/share CAGR while QCOM is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-921.03%
Negative 5Y net income/share CAGR while QCOM is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-229.33%
Negative 3Y CAGR while QCOM is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
577.65%
Dividend/share CAGR of 577.65% while QCOM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
527.45%
3Y dividend/share CAGR of 527.45% while QCOM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
9.20%
AR growth of 9.20% while QCOM is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-1.72%
Inventory is declining while QCOM stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.68%
Asset growth of 1.68% while QCOM is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
15.26%
BV/share growth of 15.26% while QCOM is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-8.56%
We’re deleveraging while QCOM stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-10.90%
We cut SG&A while QCOM invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.